Novavax's NVAX short percent of float has fallen 8.76% since its last report. The company recently reported that it has 43.91 million shares sold short, which is 36.57% of all regular shares that are ...

In the latest trading session, Novavax (NVAX) closed at $4.33, marking a +0.93% move from the previous day. This move outpaced the S&P 500's daily loss of 1.57%. Elsewhere, the Dow saw a downswing of ...

Data presented at ESCMID Global 2024 highlights the efficacy of vaccines against malaria, Streptococcus pneumoniae and more.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

NEW YORK, NY / ACCESSWIRE / April 25, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class ...

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an ...

Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.

NEW YORK, NY / ACCESSWIRE / April 25, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Novavax, Inc. (NASDAQ: NVAX). The ...

Vermont has the second lowest state fatality rate in the US (132.8 per 100K; Hawaii 104.3/100K). Mississippi (448.1/100K) and Oklahoma (445.3/100K) have the highest rates. The US average is 297.9/100K ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...